ctrl K

Advertisement

Intensity Therapeutics In... (INTS)

NASDAQ: INTS · Real-Time Price · USD

0.61

-0.03 (-4.22%)

At close: Apr 29, 2025, 3:37 PM

Intensity Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	147K	179.04K	n/a	n/a	n/a
Gross Profit	n/a	-147K	-179.04K	n/a	n/a	n/a
Operating Income	-16.59M	-8.32M	-7.63M	-8.01M	-6.22M	-5.68M
Interest Income	314K	324K	2.48K	2.61K	74.01K	150.71K
Pretax Income	-16.27M	-10.54M	-7.58M	-7.9M	-6.03M	-5.38M
Net Income	-16.27M	-10.54M	-7.45M	-7.89M	-5.96M	-5.23M
Selling & General & Admin	6.09M	3.39M	2.42M	2.16M	1.17M	1.24M
Research & Development	10.5M	4.79M	5.13M	5.86M	5.05M	4.44M
Other Expenses	n/a	n/a	47.65K	115.51K	118.76K	144.99K
Operating Expenses	16.59M	8.17M	7.55M	8.01M	6.22M	5.68M
Interest Expense	n/a	305K	81.78K	16.77K	n/a	n/a
Selling & Marketing Expenses	n/a	-147K	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	8.32M	7.55M	8.01M	6.22M	5.68M
Income Tax Expense	n/a	n/a	-131.91K	-2.61K	-74.01K	-150.71K
Shares Outstanding (Basic)	13.91M	8.62M	13.1M	13.1M	13.1M	13.1M
Shares Outstanding (Diluted)	13.91M	8.62M	13.1M	13.1M	13.1M	13.1M
EPS (Basic)	-1.17	-1.38	-0.57	-0.6	-0.45	-0.4
EPS (Diluted)	-1.17	-1.38	-0.57	-0.6	-0.45	-0.4
EBITDA	-16.59M	-10.09M	-7.4M	-7.88M	-6.03M	-5.38M
EBIT	n/a	-10.23M	-7.58M	-7.9M	-6.03M	-5.38M
Depreciation & Amortization	n/a	147K	179.04K	236.56K	206.3K	171.86K